Publicacións en colaboración con investigadores/as de Centro Nacional de Epidemiología (76)

2024

  1. Towards stronger tobacco control policies to curb the smoking epidemic in Spain

    Clinical and Translational Oncology

2023

  1. Changes in smoking cessation in Spain, 1987-2020

    Medicina Clinica, Vol. 160, Núm. 6, pp. 237-244

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Estimations of smoking-attributable mortality in Spain at a regional level: comparison of two methods

    Annals of Epidemiology, Vol. 82, pp. 77-83.e3

  4. Light cigarette smoking and all-cause mortality in Spain. A national population-based cohort study

    Annals of Epidemiology, Vol. 78, pp. 9-12

  5. Small-area models to assess the geographical distribution of tobacco consumption by sex and age in Spain

    Tobacco Induced Diseases, Vol. 21, Núm. May

2022

  1. Methodological guidelines for the estimation of attributable mortality using a prevalence-based method: the STREAMS-P tool

    Journal of Clinical Epidemiology, Vol. 147, pp. 101-110

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  3. Smoking-attributable mortality in the autonomous communities of Spain, 2017

    Revista Espanola de Cardiologia, Vol. 75, Núm. 2, pp. 150-158

  4. Trends in smoking-attributable mortality in Spain: 1990-2018

    European journal of public health, Vol. 32, Núm. 6, pp. 919-925

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004–2018

    PLoS ONE, Vol. 16, Núm. 4 April

2020

  1. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study (Scientific Reports, (2018), 8, 1, (3036), 10.1038/s41598-018-20832-0)

    Scientific Reports

  2. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  3. Smoking-Attributable Mortality in Spain in 2016

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 559-563

  4. Social inequalities in tobacco-attributable mortality in Spain. The intersection between age, sex and educational level

    PLoS ONE, Vol. 15, Núm. 9 September

2019

  1. HIV pre-exposure prophylaxis (PrEP) in Spain: political and administrative situation

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 10, pp. 656-660

  2. Prevalence of healthy lifestyles against cancer in Spanish women

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017

    PLoS ONE, Vol. 13, Núm. 10

  2. Conflicts of interest in research on electronic cigarettes

    Tobacco Induced Diseases, Vol. 16, Núm. June